Company profile
Neogen Corporation
NASDAQ: NEOG · Healthcare · Medical - Devices
#163 of 1,418 Healthcare companies by revenue37th-percentile growth
EA Score
——FH —DQ 77GM —SS 92
v0.1 · 25/100 weight · pillars only
↑ listing tenure, workforce scale · ↓ growth stability, revenue growth (YoY)
Methodology →Revenue TTM
$870.5M
Rev growth YoY (TTM)
-3.9%
Net income (FY)
-$1.1B
Employees
2,636
as of 2026-09-09
Market cap
$2.6B
as of 2026-09-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$894.7M$894.7M2025
Net income-$1.1B-$1.1B2025
Operating income-$1.1B-$1.1B2025
Total assets$3.4B$3.4B2025
Liabilities$1.4B$1.4B2025
Equity$2.1B$2.1B2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product89%
Service11%
By geography
Non-US50%
UNITED STATES50%
The read
What is Neogen Corporation’s revenue?
Neogen Corporation booked $894.7M in FY2025 revenue, contracting 3.2% year over year — slower than 63% of Healthcare companies we track, at a -122.1% net margin.
Peers · Healthcare
The Pennant Group, Inc.73BIonis Pharmaceuticals, Inc.71BInspire Medical Systems, Inc.78B+ANI Pharmaceuticals, Inc.82B+Nutex Health, Inc.68BBioCryst Pharmaceuticals, Inc.76B+Key facts
CEOMikhael Nassif
SectorHealthcare
IndustryMedical - Devices
HeadquartersLansing, MI
ExchangeNASDAQ: NEOG
Employees2,636
IPO date1989-08-23
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.